Drug name review: Science takes the spotlight in 2022

Science was the name of the game in pharma drugs last year — literally. FDA-approved drug names in 2022 leaned heavily on science associations, according to experts. While that’s not unusual, in a year of fewer approvals than any in the past six years, the overall naming conventions more often...

Click to view original post